FDA Inspection 1245488 — Laboratorio Italiano Biochimico Farmaceutico Lisapharma SPA
The FDA completed an inspection of Laboratorio Italiano Biochimico Farmaceutico Lisapharma SPA on Jan 26, 2024 in Erba. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jan 26, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Erba (Italy)
Additional details
Mutual Recognition Agreement (MRA)